首页> 美国卫生研究院文献>Glycobiology >Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose
【2h】

Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose

机译:HIV中和抗体2G12与哺乳动物寡甘露糖的细菌寡糖类似物复合的晶体结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human immunodeficiency virus-1 (HIV-1) is a major public health threat that continues to infect millions of people worldwide each year. A prophylactic vaccine remains the most cost-effective way of globally reducing and eliminating the spread of the virus. The HIV envelope spike, which is the target of many vaccine design efforts, is densely mantled with carbohydrate and several potent broadly neutralizing antibodies to HIV-1 recognize carbohydrate on the envelope spike as a major part of their epitope. However, immunizing with recombinant forms of the envelope glycoprotein does not typically elicit anti-carbohydrate antibodies. Thus, studies of alternative antigens that may serve as a starting point for carbohydrate-based immunogens are of interest. Here, we present the crystal structure of one such anti-carbohydrate HIV neutralizing antibody (2G12) in complex with the carbohydrate backbone of the lipooligosaccharide from Rhizobium radiobacter strain Rv3, which exhibits a chemical structure that naturally mimics the core high-mannose carbohydrate epitope of 2G12 on HIV-1 gp120. The structure described here provides molecular evidence of the structural homology between the Rv3 oligosaccharide and highly abundant carbohydrates on the surface of HIV-1 and raises the potential for the design of novel glycoconjugates that may find utility in efforts to develop immunogens for eliciting carbohydrate-specific neutralizing antibodies to HIV.
机译:人类免疫缺陷病毒1(HIV-1)是主要的公共健康威胁,每年继续感染全世界数百万人。预防性疫苗仍然是在全球范围内减少和消除病毒传播的最具成本效益的方法。 HIV包膜刺是许多疫苗设计工作的目标,它被碳水化合物密集地覆盖着,几种有效的广泛中和的针对HIV-1的抗体将包膜刺上的碳水化合物识别为表位的主要部分。但是,用重组形式的包膜糖蛋白免疫通常不会引发抗碳水化合物抗体。因此,可能作为基于碳水化合物的免疫原起点的替代抗原的研究是令人感兴趣的。在这里,我们介绍了一种这样的抗碳水化合物HIV中和抗体(2G12)的晶体结构,与来自根瘤菌Rv3株的脂寡糖的碳水化合物主链复合,其化学结构自然模仿了其的核心高甘露糖碳水化合物表位HIV-1 gp120上的2G12。此处描述的结构提供了Rv3寡糖与HIV-1表面上高度丰富的碳水化合物之间结构同源性的分子证据,并为设计新型糖结合物提供了潜力,这些糖结合物可用于开发激发糖特异性抗原的免疫原中和HIV的抗体。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号